By Dean Seal Shares of TC BioPharm slumped after the company said it would cut its workforce in half in a bid to extend its financial runway. The stock was.
/PRNewswire/ TC BioPharm LTD, a clinical stage biotechnology company developing an allogeneic gamma-delta T cell platform, today announces launch of a Phase.